BIOC logo

Biocept (BIOC) Depreciation And Amortization

Annual D&A

$1.66 M
+$125.00 K+8.17%

December 31, 2022

Summary

Performance

1-Year Change

+8.17%

3-Year Change

+114.02%

5-Year Change

+187.48%

15-Year Change

+187.48%

BIOC Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.25%
BIOC annual depreciation & amortization is higher than 47.25% of companies in Healthcare sector

High & Low

All-time High

$1.66 M
BIOC annual depreciation & amortization is currently at an all-time high

3-Year Low

$1.53 M
BIOC annual depreciation & amortization is currently +8.17% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BIOC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BIOC next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$57.84 M
BIOC annual total expenses is $57.84 million

Annual Operating Expenses

$29.40 M
BIOC annual total operating expenses is $29.40 million

Annual Cost Of Goods Sold

$28.44 M
BIOC annual cost of goods sold is $28.44 million

Annual Interest Expense

$316.00 K
BIOC annual interest expense is $316.00 thousand

Quarterly D&A

$370.00 K
-$244.00 K-39.74%

June 30, 2023

Summary

Performance

3-Month Change

-39.74%

1-Year Change

+4211.11%

3-Year Change

+98.71%

5-Year Change

+108.57%

BIOC Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.53%
BIOC quarterly depreciation & amortization is higher than 45.53% of companies in Healthcare sector

High & Low

All-time High

$819.00 K
BIOC quarterly depreciation & amortization is currently -54.82% below its historical high of $819.00 thousand

3-Year Low

-$9000.00

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$6.70 M
BIOC quarterly total expenses is $6.70 million

Quarterly Operating Expenses

$4.15 M
BIOC quarterly total operating expenses is $4.15 million

Quarterly Cost Of Goods Sold

$2.55 M
BIOC quarterly cost of goods sold is $2.55 million

Quarterly Interest Expense

$50.00 K
BIOC quarterly interest expense is $50.00 thousand

TTM D&A

$1.83 M
+$379.00 K+26.14%

June 30, 2023

Summary

Performance

3-Month Change

+26.14%

1-Year Change

+12.28%

3-Year Change

+134.97%

5-Year Change

+136.55%

BIOC TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.11%
BIOC TTM depreciation & amortization is higher than 48.11% of companies in Healthcare sector

High & Low

All-time High

$1.83 M
BIOC TTM depreciation & amortization is currently at an all-time high

3-Year Low

$1.45 M
BIOC TTM depreciation & amortization is currently +26.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$57.84 M
BIOC annual total expenses is $57.84 million

Annual Operating Expenses

$29.40 M
BIOC annual total operating expenses is $29.40 million

TTM Cost Of Goods Sold

$15.66 M
BIOC TTM cost of goods sold is $15.66 million

TTM Interest Expense

$195.00 K
BIOC TTM interest expense is $195.00 thousand

BIOC Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.2%+4211.1%+12.3%
3 y3 years+114.0%+98.7%+135.0%
5 y5 years+187.5%+108.6%+136.6%

BIOC Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+8.2%-54.8%+4211.1%at high+26.1%
5 y5-yearat high+114.0%-54.8%+2276.5%at high+136.6%
alltimeall timeat high+558.8%-54.8%+2276.5%at high+2531.7%

Biocept Depreciation And Amortization History

DateAnnualQuarterlyTTM
Jun 2023
-
$370.00 K(-39.7%)
$1.83 M(+26.1%)
Mar 2023
-
$614.00 K(+40.2%)
$1.45 M(-12.4%)
Dec 2022
$1.66 M(+8.2%)
$438.00 K(+7.6%)
$1.66 M(-0.6%)
Sep 2022
-
$407.00 K(-4622.2%)
$1.67 M(+2.2%)
Jun 2022
-
-$9000.00(-101.1%)
$1.63 M(+0.5%)
Mar 2022
-
$819.00 K(+82.8%)
$1.62 M(+5.9%)
Dec 2021
$1.53 M(+52.8%)
$448.00 K(+20.8%)
$1.53 M(+13.4%)
Sep 2021
-
$371.00 K(-2282.4%)
$1.35 M(+1.3%)
Jun 2021
-
-$17.00 K(-102.3%)
$1.33 M(-13.2%)
Mar 2021
-
$728.00 K(+173.0%)
$1.53 M(+53.3%)
Dec 2020
$1.00 M(+29.4%)
$266.70 K(-24.6%)
$1.00 M(+7.7%)
Sep 2020
-
$353.80 K(+90.0%)
$929.80 K(+19.5%)
Jun 2020
-
$186.20 K(-4.2%)
$778.40 K(-0.6%)
Mar 2020
-
$194.30 K(-0.6%)
$783.20 K(+1.3%)
Dec 2019
$773.30 K(-3.4%)
$195.50 K(-3.4%)
$773.20 K(-3.1%)
Sep 2019
-
$202.40 K(+6.0%)
$798.20 K(-2.5%)
Jun 2019
-
$191.00 K(+3.6%)
$819.00 K(+1.7%)
Mar 2019
-
$184.30 K(-16.4%)
$805.40 K(+0.6%)
Dec 2018
$800.90 K(+39.1%)
$220.50 K(-1.2%)
$800.90 K(+5.2%)
Sep 2018
-
$223.20 K(+25.8%)
$761.40 K(+7.7%)
Jun 2018
-
$177.40 K(-1.3%)
$706.90 K(+10.6%)
Mar 2018
-
$179.80 K(-0.7%)
$639.40 K(+11.0%)
DateAnnualQuarterlyTTM
Dec 2017
$575.70 K(+78.8%)
$181.00 K(+7.3%)
$575.80 K(+22.5%)
Sep 2017
-
$168.70 K(+53.5%)
$470.00 K(+20.5%)
Jun 2017
-
$109.90 K(-5.4%)
$390.20 K(+8.1%)
Mar 2017
-
$116.20 K(+54.5%)
$360.90 K(+12.0%)
Dec 2016
$322.00 K(+23.2%)
$75.20 K(-15.4%)
$322.10 K(+0.6%)
Sep 2016
-
$88.90 K(+10.3%)
$320.20 K(+5.1%)
Jun 2016
-
$80.60 K(+4.1%)
$304.70 K(+6.6%)
Mar 2016
-
$77.40 K(+5.6%)
$285.90 K(+9.3%)
Dec 2015
$261.40 K(+4.1%)
$73.30 K(-0.1%)
$261.50 K(-0.2%)
Sep 2015
-
$73.40 K(+18.8%)
$261.90 K(+3.2%)
Jun 2015
-
$61.80 K(+16.6%)
$253.90 K(+3.0%)
Mar 2015
-
$53.00 K(-28.1%)
$246.60 K(-1.9%)
Dec 2014
$251.20 K(-5.8%)
$73.70 K(+12.7%)
$251.30 K(+4.1%)
Sep 2014
-
$65.40 K(+20.0%)
$241.50 K(-0.2%)
Jun 2014
-
$54.50 K(-5.5%)
$242.00 K(-5.0%)
Mar 2014
-
$57.70 K(-9.7%)
$254.80 K(-4.4%)
Dec 2013
$266.60 K(-27.1%)
$63.90 K(-3.0%)
$266.60 K(+31.5%)
Sep 2013
-
$65.90 K(-2.1%)
$202.70 K(+48.2%)
Jun 2013
-
$67.30 K(-3.2%)
$136.80 K(+96.8%)
Mar 2013
-
$69.50 K
$69.50 K
Dec 2012
$365.60 K(-1.0%)
-
-
Dec 2011
$369.30 K
-
-

FAQ

  • What is Biocept annual depreciation & amortization?
  • What is the all time high annual D&A for Biocept?
  • What is Biocept annual D&A year-on-year change?
  • What is Biocept quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Biocept?
  • What is Biocept quarterly D&A year-on-year change?
  • What is Biocept TTM depreciation & amortization?
  • What is the all time high TTM D&A for Biocept?
  • What is Biocept TTM D&A year-on-year change?

What is Biocept annual depreciation & amortization?

The current annual D&A of BIOC is $1.66 M

What is the all time high annual D&A for Biocept?

Biocept all-time high annual depreciation & amortization is $1.66 M

What is Biocept annual D&A year-on-year change?

Over the past year, BIOC annual depreciation & amortization has changed by +$125.00 K (+8.17%)

What is Biocept quarterly depreciation & amortization?

The current quarterly D&A of BIOC is $370.00 K

What is the all time high quarterly D&A for Biocept?

Biocept all-time high quarterly depreciation & amortization is $819.00 K

What is Biocept quarterly D&A year-on-year change?

Over the past year, BIOC quarterly depreciation & amortization has changed by +$379.00 K (+4211.11%)

What is Biocept TTM depreciation & amortization?

The current TTM D&A of BIOC is $1.83 M

What is the all time high TTM D&A for Biocept?

Biocept all-time high TTM depreciation & amortization is $1.83 M

What is Biocept TTM D&A year-on-year change?

Over the past year, BIOC TTM depreciation & amortization has changed by +$200.00 K (+12.28%)